Abstract
Delivering pharmacologic agents directly into the brain has been proposed as a means of bypassing the blood brain barrier. However, despite 16 years of research on a number of central nervous system disorders, an effective treatment using this strategy has only been observed in the brain tumor glioblastoma multiforme. Within this study we propose a novel system for delivering drugs into the brain named the simple diffusion (SDD) system. To validate this technique, rats were subjected to a single intracranial (at the caudate nucleus), or intraperitoneal injection, of the compound citicoline, followed two hours later by a permanent middle cerebral artery occlusion (pMCAO). Results showed that 12 h after pMCAO, with 0.0025 g kg−1 citicoline, an infarct volume 1/6 the size of the intraperitoneal group was achieved with a dose 1/800 of that required for the intraperitoneal group. These results suggest that given the appropriate injection point, through SDD a pharmacologically effective concentration of citicoline can be administered.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fisher M, Feuerstein G, Howells D W, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke, 2009, 40: 2244–2250, 19246690, 10.1161/STROKEAHA.108.541128
Bobo R H, Laske D W, Akbasak A, et al. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA, 1994, 91: 2076–2080, 8134351, 10.1073/pnas.91.6.2076, 1:CAS:528:DyaK2cXit1KktL4%3D
Debinski W, Tatter S B. Convection-enhanced delivery for the treatment of brain tumors. Expert Rev Neurother, 2009, 9: 1519–1527, 19831841, 10.1586/ern.09.99, 1:CAS:528:DC%2BD1MXhsVyisbnE
Gallia G L, Brem S, Brem H. Local treatment of malignant brain tumors using implantable chemotherapeutic polymers. J Natl Compr Cancer Netw, 2005, 3: 721–728
He Q, Han H, Xu F, et al. Imaging and quantitative measurement of brain extracellular space using MRI Gd-DTPA tracer method. J Peking Univ (Health Sci), 2010, 42: 188–191
Krauze M T, Forsayeth J, Park J W, et al. Real-time imaging and quantification of brain delivery of liposomes. Pharm Res, 2006, 23: 2493–2504, 16972184, 10.1007/s11095-006-9103-5, 1:CAS:528:DC%2BD28XhtFKgu7nF
Fresta M, Puglisi G, Di Giacomo C, et al. Liposomes as in vivo carriers for citicoline: Effects on rat cerebral post-ischemic reperfusion. J Pharm Pharmacol, 1994, 46: 974–981, 7714721, 1:CAS:528:DyaK2MXivVSiurs%3D
Caravan P, Ellison J J, McMurry T J, et al. Gadolinium(iii) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem Rev, 1999, 99: 2293–2352, 11749483, 10.1021/cr980440x, 1:CAS:528:DyaK1MXlt12rsrg%3D
Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20: 84–91, 2643202, 1:STN:280:DyaL1M7gtFWhuw%3D%3D
Joshi C N, Jain S K, Murthy P S. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Brain Res Protoc, 2004, 13: 11–17, 15063836, 10.1016/j.brainresprot.2003.12.001, 1:CAS:528:DC%2BD2cXisl2rsLk%3D
Moseley M E, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: Comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med, 1990, 14: 330–346, 2345513, 10.1002/mrm.1910140218, 1:STN:280:DyaK3c3msFalsg%3D%3D
Overgaard K, Meden P. Citicoline—the first effective neuroprotectant to be combined with thrombolysis in acute ischemic stroke? J Neurol Sci, 2006, 247: 119–120, 16765988, 10.1016/j.jns.2006.05.042
Minnerup J, Schabitz W R. Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics, 2009, 6: 43–52, 19110198, 10.1016/j.nurt.2008.10.032, 1:CAS:528:DC%2BD1MXnsF2ntb4%3D
Cho H J, Kim Y J. Efficacy and safety of oral citicoline in acute ischemic stroke: Drug surveillance study in 4191 cases. Methods Find Exp Clin Pharmacol, 2009, 31: 171–176, 19536360, 10.1358/mf.2009.31.3.1364241, 1:CAS:528:DC%2BD1MXptlKru70%3D
Clark W M, Williams B J, Selzer K A, et al. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke, 1999, 30: 2592–2597, 10582983, 1:CAS:528:DyaK1MXotFWktrc%3D
Clark W M, Wechsler L R, Sabounjian L A, et al. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology, 2001, 57: 1595–1602, 11706098, 1:CAS:528:DC%2BD38Xns1w%3D
Clark W M. Efficacy of citicoline as an acute stroke treatment. Expert Opin Pharmacother, 2009, 10: 839–846, 19351232, 10.1517/14656560902765652, 1:CAS:528:DC%2BD1MXktFCmtbc%3D
Adibhatla R M, Hatcher J F. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res, 2002, 70: 133–139, 12271462, 10.1002/jnr.10403, 1:CAS:528:DC%2BD38XnvFSltLc%3D
Sykova E, Nicholson C. Diffusion in brain extracellular space. Physiol Rev, 2008, 88: 1277–1340, 18923183, 10.1152/physrev.00027.2007, 1:CAS:528:DC%2BD1cXhtlGgtbnI
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Han, H., Xia, Z., Chen, H. et al. Simple diffusion delivery via brain interstitial route for the treatment of cerebral ischemia. Sci. China Life Sci. 54, 235–239 (2011). https://doi.org/10.1007/s11427-011-4141-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-011-4141-6